David Siegel

21PUBLICATIONS
100CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyDental therapeutics, pharmacology and toxicology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 26, 2026
Overcoming Trial Exclusion: A Multicenter Analysis of Hemodialysis Multiple Myeloma Patients Who Underwent BCMA-Directed CAR-T Therapy.

|Mar 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Shaji Kumar, Sundar Jagannath, Katja C Weisel

|Jan 21, 2026
Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.

Melissa Alsina, Nina Shah, Sundar Jagannath

|Aug 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.

Sheri Skerget, Daniel Penaherrera, Ajai Chari

|Aug 17, 2023
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial.

Yi Lin, Noopur S Raje, Jesús G Berdeja

|May 10, 2023
Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study.

Saad Z Usmani, Hang Quach, Maria-Victoria Mateos

Pageof 4

Frequent Collaborators

5 joint publications

Sundar Jagannath

4 joint publications

Jesús G Berdeja

3 joint publications

Daniel Auclair

2 joint publications

Nikhil C Munshi